创伤性脑损伤后早期全身性打击:与生物标志物谱、颅内高压治疗及神经结局的相关性——CENTER-TBI数据分析
基于CENTER-TBI研究1695例TBI患者,分析早期全身性打击(低氧血症和低血压)的患病率、危险因素及其对脑损伤生物标志物、ICU治疗需求和6个月结局的影响。24.5%患者发生全身性打击(低氧16.1%、低血压15.2%、两者兼有6.8%);低血压或合并低氧者S100B、Tau、UCH-L1、NSE、NfL更高,UCH-L1/GFAP和Tau/GFAP比值在低血压者中高于无打击或单纯低氧者。6个月死亡380例(22%),GOSE≤4者759例(45%);至少一次全身性打击者死亡率31.8% vs 无打击者19%(p<0.001)。作者认为现行低血压标准可能导致更高生物标志物水平和更差结局,提示需重新审视院前血压目标。
要点
- 1695例TBI患者中24.5%发生早期全身性打击:低氧16.1%、低血压15.2%、两者兼有6.8%。
- 低血压或低血压合并低氧者S100B、Tau、UCH-L1、NSE、NfL水平更高,神经元/胶质损伤比值(UCH-L1/GFAP、Tau/GFAP)在低血压者中高于无打击或单纯低氧者。
- 至少一次全身性打击者6个月死亡率31.8% vs 无打击者19%(p<0.001)。
- 低血压或合并全身性打击与6个月不良结局显著相关;作者认为现行低血压标准较低氧标准导致更高生物标志物水平和更差结局,提示需重新审视院前血压目标。
适用人群与场景
- CENTER-TBI研究纳入的创伤性脑损伤(TBI)患者,共1695例。
研究设计与关键结果
- 研究类型为对CENTER-TBI研究的分析,纳入1695例TBI患者,评估早期全身性打击(低氧血症和低血压)的患病率、危险因素及其对脑损伤生物标志物、ICU治疗需求和6个月结局的影响。
- 24.5%患者发生全身性打击:16.1%低氧血症,15.2%低血压,6.8%两者兼有。
- 生物标志物因全身性打击类别而异:低血压或合并两种打击者S100B、Tau、UCH-L1、NSE和NfL值更高。
- 神经元/胶质损伤比值(UCH-L1/GFAP和Tau/GFAP比值)在低血压患者中高于无全身性打击或单纯低氧者。
- 6个月时380例(22%)死亡,759例(45%)GOSE≤4。
- 至少经历一次全身性打击者死亡率高于无打击者(31.8% vs 19%,p<0.001)。
- 低血压或合并全身性打击与6个月不良结局显著相关。
证据类型、等级与局限
- 证据类型:对CENTER-TBI研究的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,当前低血压标准可能导致更高生物标志物水平和更差结局,较低氧血症标准更甚,提示需要重新审视院前环境的血压目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: We analysed the impact of early systemic insults (hypoxemia and hypotension, SIs) on brain injury biomarker profiles, acute care requirements during intensive care unit (ICU) stay, and 6-month outcomes in patients with traumatic brain injury (TBI).
METHODS: From patients recruited to the Collaborative European neurotrauma effectiveness research in TBI (CENTER-TBI) study, we documented the prevalence and risk factors for SIs and analysed their effect on the levels of brain injury biomarkers [S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and protein Tau], critical care needs, and 6-month outcomes [Glasgow Outcome Scale Extended (GOSE)].
RESULTS: Among 1695 TBI patients, 24.5% had SIs: 16.1% had hypoxemia, 15.2% had hypotension, and 6.8% had both. Biomarkers differed by SI category, with higher S100B, Tau, UCH-L1, NSE and NfL values in patients with hypotension or both SIs. The ratio of neural to glial injury (quantified as UCH-L1/GFAP and Tau/GFAP ratios) was higher in patients with hypotension than in those with no SIs or hypoxia alone. At 6 months, 380 patients died (22%), and 759 (45%) had GOSE ≤ 4. Patients who experienced at least one SI had higher mortality than those who did not (31.8% vs. 19%, p < 0.001).
CONCLUSION: Though less frequent than previously described, SIs in TBI patients are associated with higher release of neuronal than glial injury biomarkers and with increased requirements for ICU therapies aimed at reducing intracranial hypertension. Hypotension or combined SIs are significantly associated with adverse 6-month outcomes. Current criteria for hypotension may lead to higher biomarker levels and more negative outcomes than those for hypoxemia suggesting a need to revisit pressure targets in the prehospital settings.
参考来源
- Robba C, Graziano F, Picetti E, et al. Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data. Intensive Care Med. 2024. PMID: 38376517. doi:10.1007/s00134-024-07324-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。